Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTreatment OutcomeTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingCombined Modality TherapyCyclophosphamideHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityRecurrenceTransplantation, IsogeneicBone Marrow DiseasesRetrospective StudiesKidney TransplantationTime FactorsMice, Inbred C57BLImmunosuppressive AgentsHematopoiesisRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFatal OutcomeAcute DiseaseBone Marrow ExaminationLeukemia, Myeloid, AcuteSurvival AnalysisGraft RejectionHematologic NeoplasmsRemission InductionPrognosisHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingTransplantation ImmunologyBone Marrow NeoplasmsFollow-Up StudiesGraft vs Host ReactionImmunosuppressionLeukemia, MyeloidLymphocyte DepletionSurvival RateAntineoplastic Combined Chemotherapy ProtocolsStem Cell TransplantationLymphoma, Non-HodgkinLeukocyte TransfusionHeart TransplantationT-LymphocytesSevere Combined ImmunodeficiencyChimeraHLA AntigensColony-Forming Units AssayMyelodysplastic SyndromesDisease-Free SurvivalLung TransplantationVirus DiseasesCyclosporineActuarial AnalysisBone DensityHematologic DiseasesLymphocyte TransfusionHodgkin DiseaseCytomegalovirus InfectionsNuclear FamilyOrgan TransplantationCell DifferentiationMice, Inbred BALB CCarmustineSpleenProspective StudiesPancytopeniaGraft vs Tumor EffectMethotrexateLeukocyte CountGraft vs Leukemia EffectCytarabineFlow CytometryCells, CulturedBone ResorptionRisk FactorsGranulocyte Colony-Stimulating FactorPostoperative ComplicationsMelphalanMice, KnockoutEtoposideLymphomaMultiple Myeloma